Clinical trial Recruiting at 1 site Observational Ages 18 and up

Pain types in people with multiple sclerosis and chronic pain

Official title: Pain Phenotyping in Multiple Sclerosis Based on IASP Criteria

Run by Kutahya Health Sciences University · NCT07766213 · Data updated 2026-11-12

This study tests how different pain types appear in people with MS who have chronic pain, to see how they relate to symptoms and quality of life.

More Chronic Pain trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorKutahya Health Sciences University
Academic / other
Locations1 site (Kütahya, Turkiye)
StatusRecruiting
StartedAugust 15, 2026
Main results expectedJune 15, 2027
Study endsSeptember 15, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT07766213 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with definite MS, chronic pain for at least 3 months, and ability to complete Turkish-language assessments.

Probably not a fit

Patients with MS and acute relapse, high-dose steroid treatment within 3 months, or non-Turkish speakers may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cross-sectional observational study enrolling adults with MS and chronic pain to classify their pain into nociceptive, neuropathic, nociplastic, or mixed phenotypes using clinical data and quantitative sensory testing. Assessments include pain characteristics, distribution, intensity, fatigue, quality of life, and MS severity, conducted in standardized conditions and focused on the most painful site. Researchers will compare characteristics across pain phenotype groups to understand associations and potential targets for management.

Why it matters

Potential benefit: If successful, the study could help tailor pain management by phenotype to improve MS-related pain and quality of life.

How similar studies have gone: Prior work suggests pain phenotyping is feasible in chronic pain but fewer MS-specific analyses exist, making this approach informative but not yet proven in MS.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Definite diagnosis of multiple sclerosis according to the McDonald criteria
* No MS relapse or high-dose steroid treatment within the previous 3 months
* Pain intensity ≥2 on the Numeric Rating Scale in at least one body region for at least 3 months
* Ability to read, understand, and communicate in Turkish

Exclusion Criteria:

* Pregnancy
* Severe psychiatric disorder and/or severe cognitive impairment confirmed by a neurologist or neuropsychiatrist
* Presence of a serious pathology or disease that may compromise the assessment process or affect clinical decision-making, including metastasis, cancer, untreated or unhealed fractures, neurological disorders other than multiple sclerosis, or a history of diabetes

Where it's running

  • Kutahya Health Sciences University Physical Medicine and Rehabilitation Department
    Kütahya, Turkiye, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.